Alagene
PrivateCompany Overview
Alagene is a biotechnology company that operates as a synthetic-biology biofoundry and contract research organization (CRO) providing end-to-end microbial product development services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
synthetic biologybiofoundrycontract research organizationCROstrain engineeringprecision fermentationmicrobial R&DDBTL pipelinehigh-throughput screeningtechno-economic analysisTEAdownstream processingbiotech outsourcingbioprocess developmentlab-as-a-servicecomputational strain design
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alagene Comparables
Compare Alagene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ingenza Ltd | 78% | |
| Manus Bio | 77% | |
| Isomerase Therapeutics Ltd. | 76% | |
Alagene Funding Rounds
Historical fundraising activity
Alagene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alagene's valuation, stock price, and market status.
See something wrong or outdated?